MOVE (Corvex, Inc. Common Stock) Stock Analysis - News
Corvex, Inc. Common Stock (MOVE) is a publicly traded Healthcare sector company. As of May 19, 2026, MOVE trades at $22.26 with a market cap of $1.23B and a P/E ratio of -1.02. MOVE moved +20.34% today. Year to date, MOVE is +243.37%; over the trailing twelve months it is +235.70%. Its 52-week range spans $3.44 to $51.31. Rallies surfaces MOVE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What changed in MOVE news today?
Corvex Q1 Revenue Jumps to $510K; Deferred Revenue Climbs to $4.4M: Corvex completed the acquisition of Corvex OpCo on March 19, 2026, renamed from Movano Inc., and delivered Q1’26 revenue of $510,000, up from $206,000 a year earlier, with deferred revenue soaring to $4.4 million. Net loss narrowed to $5.1 million while adjusted EBITDA loss improved by 67% to $1.6 million.
Mastrototaro John sold 4.51K (~$86.27K) on Jan 27, 2026.
Mastrototaro John sold 5.44K (~$109.86K) on Jan 27, 2026.
Mastrototaro John sold 14.96K (~$310.42K) on Jan 27, 2026.
MOVE Analyst Consensus
MOVE analyst coverage data. Average price target: $0.00.
Common questions about MOVE
What changed in MOVE news today?
Corvex Q1 Revenue Jumps to $510K; Deferred Revenue Climbs to $4.4M: Corvex completed the acquisition of Corvex OpCo on March 19, 2026, renamed from Movano Inc., and delivered Q1’26 revenue of $510,000, up from $206,000 a year earlier, with deferred revenue soaring to $4.4 million. Net loss narrowed to $5.1 million while adjusted EBITDA loss improved by 67% to $1.6 million.
Does Rallies summarize MOVE news?
Yes. Rallies summarizes MOVE news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is MOVE research on Rallies investment advice?
No. Rallies provides research, data, and educational context for MOVE. It does not provide personalized investment advice.
